Ardent Health (NYSE:ARDT) Releases FY 2026 Earnings Guidance

Ardent Health (NYSE:ARDT) updated its FY 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 0.780-1.150 for the period, compared to the consensus estimate of 1.220. The company issued revenue guidance of $6.4 billion-$6.7 billion, compared to the consensus revenue estimate of $6.5 billion.

Ardent Health Trading Down 0.1%

ARDT stock traded down $0.01 on Tuesday, hitting $10.74. 413,304 shares of the company were exchanged, compared to its average volume of 461,913. Ardent Health has a twelve month low of $7.71 and a twelve month high of $15.48. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 2.00. The business’s fifty day moving average is $9.83 and its two-hundred day moving average is $9.43. The stock has a market capitalization of $1.54 billion, a price-to-earnings ratio of 11.30, a price-to-earnings-growth ratio of 2.51 and a beta of 0.70.

Ardent Health (NYSE:ARDT) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.06). Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. The firm had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.59 billion. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. As a group, research analysts forecast that Ardent Health will post 1.06 earnings per share for the current year.

Analysts Set New Price Targets

ARDT has been the subject of a number of recent analyst reports. Truist Financial lowered their price target on shares of Ardent Health from $13.00 to $12.00 and set a “buy” rating for the company in a report on Tuesday, July 14th. Weiss Ratings restated a “sell (d+)” rating on shares of Ardent Health in a research note on Friday, June 12th. Royal Bank Of Canada decreased their price target on shares of Ardent Health from $13.00 to $12.00 and set an “outperform” rating for the company in a research report on Thursday, July 9th. Wall Street Zen lowered shares of Ardent Health from a “buy” rating to a “hold” rating in a research note on Sunday, July 12th. Finally, UBS Group upped their price target on shares of Ardent Health from $13.00 to $13.50 and gave the company a “buy” rating in a report on Thursday, May 7th. Seven research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $14.04.

Insider Buying and Selling at Ardent Health

In other Ardent Health news, CFO Alfred Lumsdaine purchased 10,000 shares of Ardent Health stock in a transaction dated Friday, June 5th. The shares were bought at an average cost of $8.81 per share, for a total transaction of $88,100.00. Following the transaction, the chief financial officer owned 329,183 shares in the company, valued at $2,900,102.23. This represents a 3.13% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 1.90% of the company’s stock.

Institutional Trading of Ardent Health

Institutional investors and hedge funds have recently made changes to their positions in the stock. Goldentree Asset Management LP increased its holdings in shares of Ardent Health by 99.7% in the 4th quarter. Goldentree Asset Management LP now owns 2,303,113 shares of the company’s stock worth $20,302,000 after acquiring an additional 1,150,000 shares during the period. Ameriprise Financial Inc. grew its holdings in Ardent Health by 8.2% in the 3rd quarter. Ameriprise Financial Inc. now owns 1,769,335 shares of the company’s stock worth $23,444,000 after buying an additional 134,513 shares in the last quarter. Vanguard Group Inc. increased its position in Ardent Health by 44.5% in the 3rd quarter. Vanguard Group Inc. now owns 1,352,676 shares of the company’s stock valued at $17,923,000 after acquiring an additional 416,348 shares during the period. Millennium Management LLC increased its position in Ardent Health by 6.6% in the 3rd quarter. Millennium Management LLC now owns 1,269,605 shares of the company’s stock valued at $16,822,000 after acquiring an additional 78,861 shares during the period. Finally, Bridgeway Capital Management LLC boosted its position in Ardent Health by 108.2% during the 4th quarter. Bridgeway Capital Management LLC now owns 946,571 shares of the company’s stock worth $8,358,000 after acquiring an additional 491,961 shares during the period.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.